Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles

✍ Scribed by Cunningham, David; Hawkes, Eliza A; Jack, Andrew; Qian, Wendi; Smith, Paul; Mouncey, Paul; Pocock, Christopher; Ardeshna, Kirit M; Radford, John A; McMillan, Andrew; Davies, John; Turner, Deborah; Kruger, Anton; Johnson, Peter; Gambell, Joanna; Linch, David

• Book ID: 120231094
• Publisher: The Lancet
• Year: 2013
• Tongue: English
• Weight: 429 KB
• Volume: 381
• Category: Article
• ISSN: 0140-6736
• DOI: 10.1016/S0140-6736(13)60313-X